Quercetin ameliorates insulin sensitivity and liver steatosis partly by increasing adiponectin expression in ob/ob mice
- Document Type
- Publications · Journal Article
- Registered DB
- KCISCIEScopus
- Journal Ranking
- JCR Q4Scopus Q3
- Journal
- Food Science and Biotechnology24(1) · pp.273 · 2015
- Citation
- Web of Science 34KCI 0
- JCR IF
- JCR 2014 0.653
- ISSN
- 1226-7708
Authors
- 최하늘First author인제대학교
- Jeong Soo Mi부산대학교
- 허경혜인제대학교
- 김정인Corresponding author인제대학교
Abstract
The effects of quercetin on non-alcoholic fatty liver disease (NAFLD) in an obese mouse model were investigated. Five-week-old ob/ob mice were fed an AIN-93G diet or a diet containing 0.08% quercetin, whereas ob/+ mice were provided the AIN-93G diet for 10 weeks. Quercetin significantly decreased serum glucose, triglycerides, cholesterol, and free fatty acid (FFA) levels, and homeostasis model assessment for insulin resistance (HOMA-IR) values, compared with the ob/ob control group. Quercetin lowered hepatic total lipids, triglycerides, and cholesterol levels, and the serum alanine transaminase (ALT) activities, compared with the ob/ob control group. Quercetin increased adiponectin protein expression in epididymal adipose tissue and serum adiponectin levels, and decreased serum tumor necrosis factor-alpha (TNF-alpha) and monocyte chemotactic protein-1 (MCP-1), compared with the ob/ob control group. These results indicate that quercetin could exert protective effects against development of NAFLD, partly by overexpression of adiponectin and reduction of inflammatory cytokine levels in ob/ob mice.
Keywords
quercetinadiponectinsteatosistriglycerideinflammationMETABOLIC SYNDROMEADIPOSE-TISSUEANIMAL-MODELSRESISTANCEDISEASEOBESITYALPHADIETHYPERGLYCEMIARECEPTORS
Identifiers
- WoS UID
- 000347530500036
- KCI
- ART001966024



Login
Back to Publication list